CH

Chai Communication Co., LTD.

An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.

351870 | KO

Overview

Corporate Details

ISIN(s):
KR7351870001
LEI:
Country:
South Korea
Address:
서울특별시 강남구 학동로43길 6, 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Chai Communication Co., Ltd. is an AD-Tech based comprehensive digital advertising and marketing company. Established in 2004, the company offers a full suite of digital marketing services, including online advertising campaigns, social media marketing, keyword search optimization, and advertising production such as brand films and banner ads. Chai Communication leverages data and technology to deliver creative and effective advertising solutions, aiming to create a distinct difference for its clients' brands in the digital space.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 392.6 KB
2025-08-29 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-31 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 397.7 KB
2025-07-28 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 402.4 KB
2025-07-11 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 407.1 KB
2025-06-26 00:00
M&A Activity
타법인주식및출자증권취득결정
Korean 25.0 KB
2025-06-13 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 413.1 KB
2025-05-30 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.4 MB
2025-05-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 420.1 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 32.9 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.4 KB
2025-03-31 00:00
Remuneration Information
주식매수선택권부여에관한신고
Korean 164.9 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-21 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 450.2 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 220.0 KB

Automate Your Workflow. Get a real-time feed of all Chai Communication Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chai Communication Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chai Communication Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.